Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection

Currently, there is no effective vaccine to prevent hepatitis C virus (HCV) infection, partly due to our insufficient understanding of the virus glycoprotein immunology. Most neutralizing antibodies (nAbs) were identified using glycoprotein immunogens, such as recombinant E1E2, HCV pseudoparticles o...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Kai, Liu, Ruyu, Rao, Huiying, Jiang, Dong, Wang, Jianghua, Xie, Xingwang, Wei, Lai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583415/
https://www.ncbi.nlm.nih.gov/pubmed/26406225
http://dx.doi.org/10.1371/journal.pone.0138756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583415/
https://www.ncbi.nlm.nih.gov/pubmed/26406225
http://dx.doi.org/10.1371/journal.pone.0138756

Ejemplares similares